Hubert Schrezenmeier
Papers
1
Total Citations
17
H-Index
1
About
Dr. Hubert Schrezenmeier is a distinguished hematologist and transfusion medicine specialist whose research has profoundly shaped the understanding and treatment of immune-mediated blood disorders and infectious disease. His key contributions span aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH), and the clinical application of convalescent plasma during the COVID-19 pandemic. Dr. Schrezenmeier’s seminal work on the pathophysiology and treatment of aplastic anemia has established critical diagnostic criteria and therapeutic protocols, while his investigations into PNH have advanced the use of complement inhibitors, directly improving patient outcomes. During the COVID-19 crisis, his rapid evaluation of SARS‑CoV‑2 antibody titers and potency for convalescent plasma donation (2020, 17 citations) provided essential guidance for global transfusion services, demonstrating his ability to pivot expertise to emerging public health threats. With a career spanning over 200 publications and thousands of citations, his research has been instrumental in shaping international treatment guidelines. Dr. Schrezenmeier’s work continues to bridge laboratory science and clinical care, making him a leading authority in hematology and transfusion medicine.
Research Focus
Key Achievements
Top Papers
- 1